CELL THERAPEUTICS

Brand Owner Address Description
CTI CTI BIOPHARMA CORP. 3101 Western Avenue Seattle WA 98121 CELL THERAPEUTICS, INC.;Research and development of pharmaceutical preparations; product research and development for others in the field of pharmaceutical preparations; product research and development services, namely, assessing intended target recipients of pharmaceutical preparations and positioning pharmaceutical preparations for success in clinical development and commercial use; and providing technical consultation in the field of pharmaceutical product research and development;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention comprises a method for producing mammalian therapeutics free from prion contamination and cells for use in such methods. Such therapeutics are produced in somatic cells having a genome with an artificially altered PrP gene. The PrP gene in these cells may be ablated, or replaced by an exogenous inducible form of the PrP gene. The endogenous gene in the host cells may be disrupted, or disrupted and replaced by an exogenous PrP gene.